According to aTyr Pharma's latest financial reports the company's current EPS (TTM) is -0,85 โฌ. In 2022 the company made an earnings per share (EPS) of -1,45 โฌ an increase over its 2021 EPS that were of -1,70 โฌ.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -0,87 โฌ | |
2022 | -1,45 โฌ | -14.89% |
2021 | -1,70 โฌ | 18.24% |
2020 | -1,44 โฌ | -78.37% |
2019 | -6,65 โฌ | -54.6% |
2018 | -14,65 โฌ | -38.81% |
2017 | -23,95 โฌ | -22.54% |
2016 | -30,91 โฌ | 5.07% |
2015 | -29,42 โฌ |